Skip to main content
PMC home page
Neuroscience Bulletin logoLink to Neuroscience Bulletin
. 2008 Feb 27;24(1):13–20. doi: 10.1007/s12264-008-1017-2

An inhibition of ceruloplasmin expression induced by cerebral ischemia in the cortex and hippocampus of rats

脑缺血对大鼠皮层及海马铜蓝蛋白表达的影响

Yan-Wei Li 1,2, Lin Li 1,✉, Jin-Ying Zhao 2
PMCID: PMC5552519  PMID: 18273071

Abstract

Objective

To explore effects of cerebral ischemia on the ceruloplasmin (Cp) expression in the cortex and hippocampus of rats.

Methods

Male Wistar rats were randomly divided into cerebral ischemia group and control group. Cerebral ischemia was induced by ligating bilateral common carotid arteries and the ischemic rats were further subgrouped according to ischemia time. The control rats received a sham operation. The expression of Cp mRNA in the cortex and hippocampus was measured by reverse transcription polymerase chain reaction (RT-PCR). The Cp expression was shown by immunohistochemistrical (streptavidin peroxidase, SP) method.

Results

In ischemia group, the expression of Cp mRNA in the cortex and hippocampus decreased compared with that in control group (P < 0.01); and the longer rats experienced cerebral ischemia, the lower Cp mRNA expressed. By immunohistochemistry, Cp was shown expressed in the neural cells including epithelial cells of choroid plexus, ependymal cells, astrocytes of cortex and hippocampus, and vascular endothelial cells, but not in pyramidal cells and granulosa cells of cortex and hippocampus. Cp levels in the cortex and hippocampus decreased in rats suffering from cerebral ischemia for 3 d, 7 d and 28 d but not in rats exposed to ischemia for 1 d compared with that in control group (P < 0.05). Iron concentration correlated negatively with Cp expression in the cortex and hippocampus of rats exposure to ischemia (the cortex, r = −0.831, P < 0.01; the hippocampus, r = −0.809, P < 0.01).

Conclusion

Cerebral ischemia inhibited Cp expression in the cortex and hippocampus of rats. The decrease of Cp might be involved in iron deposition in neurons.

Keywords: cerebral ischemia, brain iron concentration, ceruloplasmin

References

  • [1].Jeong S.Y., David S. Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice. J Neurosci. 2006;26:9810–9819. doi: 10.1523/JNEUROSCI.2922-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Patel B.N., David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem. 1997;272:20185–20190. doi: 10.1074/jbc.272.32.20185. [DOI] [PubMed] [Google Scholar]
  • [3].Patel B.N., Dunn R.J., David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem. 2000;275:4305–4310. doi: 10.1074/jbc.275.6.4305. [DOI] [PubMed] [Google Scholar]
  • [4].Morita H., Inoue A., Yanagisawa N. A case of ceruloplasmin deficiency which showed dementia, ataxia and iron deposition in the brain. Rinsho Shinkeigaku. 1992;32:483–487. [PubMed] [Google Scholar]
  • [5].Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci. 2002;22:6578–6586. doi: 10.1523/JNEUROSCI.22-15-06578.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Qian Z.M., Ke Y. Rethinking the role of ceruloplasmin in brain iron metabolism. Brain Res Brain Res Rev. 2001;35:287–294. doi: 10.1016/S0165-0173(01)00056-X. [DOI] [PubMed] [Google Scholar]
  • [7].Qian Z.M., Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Rev. 1998;27:257–267. doi: 10.1016/S0165-0173(98)00012-5. [DOI] [PubMed] [Google Scholar]
  • [8].Li Y.W., Zhao J.Y., Li L. Changes of iron concentration and expression of ferroportin1 in the cortex and hippocampus of rats induced by cerebral ischemia. J Shanxi Med Uni. 2007;38:487–490. [Google Scholar]
  • [9].Qian Z.M., Shen X. Brain iron transport and neurodegeneration. Trend Mol Med. 2001;7:103–108. doi: 10.1016/S1471-4914(00)01910-9. [DOI] [PubMed] [Google Scholar]
  • [10].Wakita H., Tomimoto H., Akiguchi I., Kimura J. Glia activation and white matter change in the rat brain induced by chronic cerebral hypoperfusion: an immunohischemical study. Acta Neuro-pathol (Berl) 1994;87:484–492. doi: 10.1007/BF00294175. [DOI] [PubMed] [Google Scholar]
  • [11].Chen L., Dentchev T., Wong R., Hahn P., Wen R., Bennett J., et al. Increased expression of ceruloplasmin in the retina following photic Injury. Molecular Vision. 2003;9:151–158. [PubMed] [Google Scholar]
  • [12].Shen H. Quantitative method studies of immunohistochemistry staining. Chin J Histochem Cytochem. 1995;4:89–92. [Google Scholar]
  • [13].Kondo Y., Ogawa N., Asanuma M., Ota Z., Mori A. Regional differences in late-onset iron deposition, ferritin, transferrin, astrocyte proliferation, and microglial activation after transient forebrain ischemia in rat brain. J Cereb Blood Flow Metab. 1995;15:216–226. doi: 10.1038/jcbfm.1995.27. [DOI] [PubMed] [Google Scholar]
  • [14].Ishimaru H., Ishikawa K., Ohe Y., Takahashi A., Tatemoto K., Maruyama Y. Activation of iron handling system within the gerbil hippocampus after cerebral ischemia. Brain Res. 1996;726:23–30. doi: 10.1016/0006-8993(96)00294-6. [DOI] [PubMed] [Google Scholar]
  • [15].Chi S.I., Wang C.K., Chen J.J., Chau L.Y., Lin T.N. Differential regulation of H-and L-ferritin messenger RNA subunits, ferritin protein and iron following focal cerebral ischemia-reperfusion. Neuroscience. 2000;100:475–484. doi: 10.1016/S0306-4522(00)00317-1. [DOI] [PubMed] [Google Scholar]
  • [16].Klomp L.W., Farhangrazi Z.S., Dugan L.L., Gitlin J.D. Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest. 1996;98:207–215. doi: 10.1172/JCI118768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Klomp L.W., Gitlin J.D. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet. 1996;5:1989–1996. doi: 10.1093/hmg/5.12.1989. [DOI] [PubMed] [Google Scholar]
  • [18].Hellman N.E., Gitlin J.D. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002;22:439–458. doi: 10.1146/annurev.nutr.22.012502.114457. [DOI] [PubMed] [Google Scholar]
  • [19].Osaki S., Johnson D.A., Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem. 1966;241:2746–2751. [PubMed] [Google Scholar]
  • [20].Jeong S.Y., David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem. 2003;278:27144–27148. doi: 10.1074/jbc.M301988200. [DOI] [PubMed] [Google Scholar]
  • [21].Qian Z.M., Tsoi Y.K., Ke Y., Wong M.S. Ceruloplasmin promotes iron uptake rather than release in BT325 cells. Exp Brain Res. 2001;140:369–374. doi: 10.1007/s002210100831. [DOI] [PubMed] [Google Scholar]
  • [22].Xie J.X., Tsoi Y.K., Chang Y.Z., Ke Y., Qian Z.M. Effects of ferroxidase activity and species on ceruloplasmin mediated iron uptake by BT325 cells. Brain Res Mol Brain Res. 2002;99:12–16. doi: 10.1016/S0169-328X(01)00336-9. [DOI] [PubMed] [Google Scholar]
  • [23].Ke Y., Ho K., Du J. e. a1. Role of soluble ceruloplasmin in iron uptake by midbrain and hippocampus neurons. J Cell Biochem. 2006;98:912–919. doi: 10.1002/jcb.20740. [DOI] [PubMed] [Google Scholar]
  • [24].Reilly C.A., Aust S.D. Stimulation of the ferroxidase activity of ceruloplasmin during iron loading into ferritin. Arch Biochem Biophys. 1997;347:242–248. doi: 10.1006/abbi.1997.0351. [DOI] [PubMed] [Google Scholar]
  • [25].Van Eden M.E., Aust S.D. Intact human ceruloplasmin is required for the incorporation of iron into human ferritin. Arch Biochem Biophys. 2000;381:119–126. doi: 10.1006/abbi.2000.1952. [DOI] [PubMed] [Google Scholar]

Articles from Neuroscience Bulletin are provided here courtesy of Springer

RESOURCES